VASCULOPATHY, APOPTOSIS AND AUTOIMMUNITY
VASCULOPATHY, APOPTOSIS AND AUTOIMMUNITY
批准号:
6082269
负责人:
Joseph M Ahearn
金额:
$20.25万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-27 至 2002-08-31
关键词:
B lymphocyte DNA topoisomerases SDS polyacrylamide gel electrophoresis Sf9 cell line T lymphocyte antigen presenting cell apoptosis autoantigens autoimmunity biopsy cellular immunity clinical research complement pathway complement receptor cytokine enzyme linked immunosorbent assay flow cytometry high performance liquid chromatography human subject immune tolerance /unresponsiveness ion exchange chromatography leukocyte activation /transformation molecular cloning molecular pathology systemic scleroderma western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal is focused upon the molecular mechanism by which vasculopathy leads to fibrotic and autoimmune manifestations of systemic sclerosis. Autoantibodies generated by patients with systemic sclerosis are uniquely targeted to nucleolar proteins such as DNA topoisomerase I (topo-I). It has been demonstrated that topo-I is a substrate for protease(s) specific to the apoptotic process, resulting in novel cleavage fragments that may reveal cryptic epitopes to which the host has not previously been tolerized. It has also been recently demonstrated that several of the autoantigens targeted in diffuse scleroderma are uniquely susceptible to cleavage by metal-catalyzed oxidation reactions similar to what may occur during ischemia-reperfusion in the presence of appropriate metals. This process may also reveal immunocryptic epitopes and provides a molecular explanation for why certain proteins are uniquely targeted by the immune response in systemic sclerosis. However, it is well known that a cryptic epitope alone is not sufficient to generate autoreactivity, which also requires the participation of a molecular adjuvant, and uptake of the potential autoantigen by an antigen presenting cell (APC) with costimulatory capacity. The central hypothesis of this proposal is that chronic ischemia-reperfusion injury in patients with systemic sclerosis not only generates immunocryptic epitopes within nucleolar autoantigens of cutaneous origin, but it also generates complement ligands that provide the molecular adjuvant required to break immune tolerance. The specific aims of this proposal are to: 1) Determine the capacity of apoptotic blebs bearing complement ligands to modulate the cytokine expression and costimulatory capacity of antigen presenting cells, 2) characterize the immune responses to self antigen- containing apoptotic blebs, and 3) examine the role of complement ligand C3d during induction of autoreactive T and B cell responses to topo I in vitro. Although systemic sclerosis is the focus of this proposal, the data generated by these studies should provide insight into our understanding of vasculopathic and autoimmune processes in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Complement, Cardiovascular Disease, and SLE
-
批准号:6805641
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Erythrocytes as Time Capsules of Disease Activity in SLE
-
批准号:6772602
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Erythrocytes as Time Capsules of Disease Activity in SLE
-
批准号:7105057
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Erythrocytes as Time Capsules of Disease Activity in SLE
-
批准号:6924619
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Complement, Cardiovascular Disease, and SLE
-
批准号:6733758
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Complement, Cardiovascular Disease, and SLE
-
批准号:6898927
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Complement, Cardiovascular Disease, and SLE
-
批准号:7077805
-
项目类别:
-
资助金额:$29.76万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Erythrocytes as Time Capsules of Disease Activity in Systemic Lupus Erythematosus
-
批准号:7253944
-
项目类别:
-
资助金额:$28.16万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
Erythrocytes as Time Capsules of Disease Activity in SLE
-
批准号:6677400
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2003
-
负责人:Joseph M Ahearn
-
依托单位:
DAMAGE AND PATHOLOGIC FRACTURE IN VERTEBRAL BODIES
-
批准号:6232932
-
项目类别:
-
资助金额:$57.81万
-
财政年份:2001
-
负责人:Joseph M Ahearn
-
依托单位:
Rheumatic Diseases Core Center
-
批准号:6632786
-
项目类别:
-
资助金额:$57.39万
-
财政年份:2001
-
负责人:Joseph M Ahearn
-
依托单位:
Rheumatic Diseases Core Center
-
批准号:6732005
-
项目类别:
-
资助金额:$58.77万
-
财政年份:2001
-
负责人:Joseph M Ahearn
-
依托单位:
Rheumatic Diseases Core Center
-
批准号:6947774
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2001
-
负责人:Joseph M Ahearn
-
依托单位:
Rheumatic Diseases Core Center
-
批准号:6512216
-
项目类别:
-
资助金额:$56.35万
-
财政年份:2001
-
负责人:Joseph M Ahearn
-
依托单位:
VASCULOPATHY, APOPTOSIS AND AUTOIMMUNITY
-
批准号:6534497
-
项目类别:
-
资助金额:$26.25万
-
财政年份:1999
-
负责人:Joseph M Ahearn
-
依托单位:
VASCULOPATHY, APOPTOSIS AND AUTOIMMUNITY
-
批准号:6655100
-
项目类别:
-
资助金额:$26.25万
-
财政年份:1999
-
负责人:Joseph M Ahearn
-
依托单位:
VASCULOPATHY, APOPTOSIS AND AUTOIMMUNITY
-
批准号:6315404
-
项目类别:
-
资助金额:$6.0万
-
财政年份:1999
-
负责人:Joseph M Ahearn
-
依托单位:
VASCULOPATHY, APOPTOSIS AND AUTOIMMUNITY
-
批准号:6375300
-
项目类别:
-
资助金额:$26.25万
-
财政年份:1999
-
负责人:Joseph M Ahearn
-
依托单位:
VASCULOPATHY, APOPTOSIS AND AUTOIMMUNITY
-
批准号:6171627
-
项目类别:
-
资助金额:$26.25万
-
财政年份:1999
-
负责人:Joseph M Ahearn
-
依托单位:
TARGETED IMMUNOGEN DELIVERY TO MURINE DENDRITIC CELLS
-
批准号:6099901
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:Joseph M Ahearn
-
依托单位:
海外基金